Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells.
about
N-Glycosylation influences the structure and self-association abilities of recombinant nucleolinSubcellular fractionation and localization studies reveal a direct interaction of the fragile X mental retardation protein (FMRP) with nucleolinThe HIV-1 gp120 inhibits the binding of adenosine deaminase to CD26 by a mechanism modulated by CD4 and CXCR4 expressionThe anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptorPleiotrophin inhibits HIV infection by binding the cell surface-expressed nucleolinThe anti-HIV pentameric pseudopeptide HB-19 is preferentially taken up in vivo by lymphoid organs where it forms a complex with nucleolinEcto-protein kinase substrate p120 revealed as the cell-surface-expressed nucleolar phosphoprotein Nopp140: a candidate protein for extracellular Ca2+-sensingThe anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycansNovel checkpoint response to genotoxic stress mediated by nucleolin-replication protein a complex formation.A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu.Surface expressed nucleolin is constantly induced in tumor cells to mediate calcium-dependent ligand internalization.The carboxy-terminal fragment of nucleolin interacts with the nucleocapsid domain of retroviral gag proteins and inhibits virion assembly.Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell typeThe cellular protein nucleolin preferentially binds long-looped G-quadruplex nucleic acids.Nuclear targeting by the growth factor midkine.Shiga toxin of enterohemorrhagic Escherichia coli type O157:H7 promotes intestinal colonization.Cracking the ANP32 whips: important functions, unequal requirement, and hints at disease implications.Nucleolin stabilizes G-quadruplex structures folded by the LTR promoter and silences HIV-1 viral transcription.Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin.Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancerCell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands.Midkine in the pathology of cancer, neural disease, and inflammation.The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells.Inhibition of DNA replication and induction of S phase cell cycle arrest by G-rich oligonucleotides.Nucleolin-mediated cellular trafficking of DNA nanoparticle is lipid raft and microtubule dependent and can be modulated by glucocorticoid.The pseudopeptide HB-19 binds to cell surface nucleolin and inhibits angiogenesis.Identification of nucleolin as a new L-selectin ligand.Cell surface-localized nucleolin is a eukaryotic receptor for the adhesin intimin-gamma of enterohemorrhagic Escherichia coli O157:H7.Apoptosis in leukemia cells is accompanied by alterations in the levels and localization of nucleolin.
P2860
Q24302516-184ABDE1-79FF-498F-8A71-CFA9A94A647EQ28114773-B7E8FE61-60F5-49E5-AA5F-4D3B0C6F5A56Q28141057-9E89D81B-BF8D-49DF-9FEC-9AA5A07939E7Q28216327-A1BF4D82-4BAB-42E0-8AA0-79B2B363B36AQ28271787-7C95DCAB-7ED0-48D9-AD05-22A15739EC29Q28363541-4B84E30F-1F97-4824-A350-C82B04A9CF82Q28365833-B408D030-54E4-4A26-AB22-F25E8C130367Q28372900-4AF9F9D4-CE7C-4569-B526-E485815C77E2Q31150971-B51CAF34-83E2-4515-AC23-A031383D9609Q33369228-A8657F68-7BF3-4D6B-A073-272CF2BDE5E1Q33784401-7518E945-6697-4AB6-973D-32FF45622DC3Q33826575-BEDADCC8-B29F-4594-A877-33EE4DC55C4FQ33980633-F96ADF68-598F-4F8F-9A33-C80C817CB70DQ34047740-1669DC4F-7EB0-438D-B686-B6089ECBC3D2Q34286252-C7074098-BA47-4E80-99C0-902ECA449323Q34667008-CFC84F92-45D2-43A2-A0FE-44DBD928EBDBQ34730329-57CE003A-55FE-4BE5-A922-6B721686D1A0Q36160697-BDC45C7C-2E72-458F-A057-805A06BA5BF7Q36394982-BA6E701E-9C04-45BC-B2DD-23903FCE80FEQ37277677-8858C54C-65CA-41E7-A65C-FC49A1369D9CQ37698301-2224F4DB-2D42-4302-A85B-0FED7DEE70BFQ38020971-B06A1EA3-E892-496A-A6F1-10DB4701258DQ38290769-63BACA40-9538-456C-8DF9-6AA52757A161Q38297014-08CF165B-8558-4156-8B62-56C96AE65337Q38339978-46D08791-9289-4AA9-A0F9-E1FC583490F1Q39232685-0205DE4D-7A71-45A5-810B-9666C9095317Q40764932-13520F9C-2BD6-4CEE-8F11-04EECF4A5DC2Q40769297-2A14E483-A2BE-45B6-8862-35C411C7150EQ44265598-0955E51E-D63B-4FE0-8047-6BF85A29FB50
P2860
Identification of V3 loop-binding proteins as potential receptors implicated in the binding of HIV particles to CD4(+) cells.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Identification of V3 loop-bind ...... inding of HIV particles to CD4
@nl
Identification of V3 loop-bind ...... HIV particles to CD4(+) cells.
@en
type
label
Identification of V3 loop-bind ...... inding of HIV particles to CD4
@nl
Identification of V3 loop-bind ...... HIV particles to CD4(+) cells.
@en
prefLabel
Identification of V3 loop-bind ...... inding of HIV particles to CD4
@nl
Identification of V3 loop-bind ...... HIV particles to CD4(+) cells.
@en
P2093
P2860
P50
P356
P1476
Identification of V3 loop-bind ...... HIV particles to CD4(+) cells
@en
P2093
A G Hovanessian
C Callebaut
J P Briand
P2860
P304
21988-21997
P356
10.1074/JBC.273.34.21988
P407
P577
1998-08-01T00:00:00Z